Analysis of polymorphisms of tumor necrosis factor-α and polymorphic xenobiotic metabolizing enzymes in inflammatory bowel disease: Study from northern India

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 6, 2007, Pages 920-924

  Mittal, Rama D ^a   Manchanda, Parmeet K ^a   Bid, Hemant K ^a   Ghoshal, Uday C ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Crohn's disease; Genetic polymorphism; Glutathione S transferase; Inflammatory bowel disease; Tumor necrosis factor ; Ulcerative colitis

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; TUMOR NECROSIS FACTOR ALPHA; XENOBIOTIC AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MULTIPLEX POLYMERASE CHAIN REACTION; NULL ALLELE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; ULCERATIVE COLITIS;

EID: 34250325955     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04538.x     Document Type: Article

References (27)

1. Figueroa CC, Quera PR, Valenzuela EJ, Jensen BC. Inflammatory bowel disease: experience of two Chilean centers. Rev. Med. Chil. 2005 133 : 1295 304.
2. Binder V. Genetic epidemiology in inflammatory bowel diseases. Dig. Dis. 1998 16 : 351 5.
3. Roberts-Thomson IC, Butler WJ. Polymorphism and ulcerative colitis. J. Gastroenterol. Hepatol. 2005 20 : 157 8.
4. Duncan H, Swan C, Green J et al. Susceptibility to ulcerative colitis and Crohn's disease: interactions between glutathione S-transferase GSTM1 and GSTT1 genotypes. Clin. Chim. Acta 1995 240 : 53 61.
5. Hugot JP, Thomas G. Genome-wide scanning in inflammatory bowel diseases. Dig. Dis. 1998 16 : 364 9.
6. Korkina L, Suprun M, Petrova A, Mikhal'chik E, Luci A, De Luca C. The protective and healing effects of a natural antioxidant formulation based on ubiquinol and Aloe vera against dextran sulfate-induced ulcerative colitis in rats. Biofactors 2003 18 : 255 64.
7. Crotty B. Ulcerative colitis and xenobiotic metabolism. Lancet 1994 343 : 35 8.
8. Hampe J, Shaw SH, Saiz R et al. Linkage of inflammatory bowel disease to human chromosome 6p. Am. J. Hum. Genet. 1999 65 : 1647 55.
9. Hertervig E, Nilsson A, Seidegard J. The expression of glutathione transferase mu in patients with inflammatory bowel disease. Scand. J. Gastroenterol. 1994 29 : 729 35.
10. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol. Biomarkers Prev. 1997 6 : 733 43.
11. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor-α promoter on transcriptional activation. Proc. Natl. Acad. Sci. USA 1997 94 : 3195 9.
12. Hayes JD, Strange RC. Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress. Free Radic. Res. 1995 22 : 193 207.
13. Sood A, Midha V, Sood N, Bhatia AS, Avasthi G. Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut 2003 52 : 1587 90.
14. Stange EF, Travis SP, Vermeire S et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 2006 55 (Suppl. 1 i1 15.
15. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res. 1988 16 : 1215.
16. Tsai FJ, Lu HF, Yeh LS, Hsu CD, Chen WC. Lack of evidence for the association of tumor necrosis factor-alpha gene promoter polymorphism with calcium oxalate stone and bladder cancer patients. Urol. Res. 2001 29 : 412 16.
17. Abdel-Rahman SZ, Anwar WA, Abdel-Aal WE, Mostafa HM, Au WW. GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer. Cancer Detect. Prev. 1998 22 : 129 38.
18. Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 1994 106 : 533 9.
19. Komatsu M, Kobayashi D, Saito K et al. Tumor necrosis factor-alpha in serum of patients with inflammatory bowel disease as measured by highly sensitive immuno-PCR. Clin. Chem. 2001 47 : 1297 301.
20. Brinkman BM, Zuijdeest D, Kaijzel EL, Breedveld FC, Verweij CL. Relevance of the tumor necrosis alpha (TNF alpha) -308 prompter polymorphism in TNF alpha gene regulation. J. Inflamm. 1995 46 : 32 41.
21. Louis E, Satsangi J, Roussomoustakaki M et al. Cytokine gene polymorphisms in inflammatory bowel disease. Gut 1996 39 : 705 10.
22. Kawasaki A, Tsuchiya N, Hagiwara K et al. Independent contribution of HLA-DRB1 and TNF alpha promoter polymorphisms to the susceptibility to Crohn's disease. Genes Immun. 2000 1 : 351 7.
23. Cantor MJ, Nickerson P, Bernstein CN. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease. Am. J. Gastroenterol. 2005 100 : 1134 42.
24. Song Y, Wu KC, Zhang L et al. Correlation between a gene polymorphism of tumor necrosis factor and inflammatory bowel disease. Chin. J. Dig. Dis. 2005 6 : 170 4.
25. Zipperlen K, Peddle L, Melay B, Hefferton D, Rahman P. Association of TNF-alpha polymorphisms in Crohn's disease. Hum. Immunol. 2005 66 : 56 9.
26. Heagerty AH, Fitzgerald D, Smith A et al. Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumours. Lancet 1994 343 : 266 8.
27. Simmonds NJ, Rampton DS. Inflammatory bowel disease - a radical view. Gut 1993 34 : 865 8.